Podda, E.; Acca, S.; Aragoni, M.C.; Lippolis, V.; Pintus, A.; Arca, M.; Sforazzini, G.
5-((3′,5′-Dibromo-[2,2′-bithiophen]-5-yl)methyl)-3-ethyl-2-thioxothiazolidin-4-one∙Br2 (1:1). Molbank 2025, 2025, M2047.
https://doi.org/10.3390/M2047
AMA Style
Podda E, Acca S, Aragoni MC, Lippolis V, Pintus A, Arca M, Sforazzini G.
5-((3′,5′-Dibromo-[2,2′-bithiophen]-5-yl)methyl)-3-ethyl-2-thioxothiazolidin-4-one∙Br2 (1:1). Molbank. 2025; 2025(3):M2047.
https://doi.org/10.3390/M2047
Chicago/Turabian Style
Podda, Enrico, Simone Acca, Maria Carla Aragoni, Vito Lippolis, Anna Pintus, Massimiliano Arca, and Giuseppe Sforazzini.
2025. "5-((3′,5′-Dibromo-[2,2′-bithiophen]-5-yl)methyl)-3-ethyl-2-thioxothiazolidin-4-one∙Br2 (1:1)" Molbank 2025, no. 3: M2047.
https://doi.org/10.3390/M2047
APA Style
Podda, E., Acca, S., Aragoni, M. C., Lippolis, V., Pintus, A., Arca, M., & Sforazzini, G.
(2025). 5-((3′,5′-Dibromo-[2,2′-bithiophen]-5-yl)methyl)-3-ethyl-2-thioxothiazolidin-4-one∙Br2 (1:1). Molbank, 2025(3), M2047.
https://doi.org/10.3390/M2047